Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 91, Issue -, Pages 216-224Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2016.05.015
Keywords
Collagen; Collagen hydrolysate; Ulcerative colitis; Mucosal damage
Categories
Funding
- Council of Scientific and Industrial Research (CSIR) under the M2D XII plan project [CSC 0134]
- CSIR
Ask authors/readers for more resources
Ulcerative colitis, particularly the chronic persistent form is characterized by the presence of active inflammation and extensive areas of ulceration in the colonic mucosa. The existing treatment protocol aims at only reducing intestinal inflammation, rather than targeting mucosal ulceration. In this study, type I collagen and its daughter peptides called collagen hydrolysate, highly popular reconstructive materials for tissue engineering applications, are hypothesized as healing matrices to target the recuperation of internal mucosal ulceration. The clinical assessments on day 10 of dextran sodium sulfate induced colitis in mice model revealed that both the collagen (1.56 +/- 0.29) and collagen hydrolysate treatments (1.33 +/- 0.33) showed a significant reduction in the rectal bleeding compared to the reference mesalamine treatment (2.50 +/- 0.33) and untreated negative control (2.40 +/- 0.40). VEGF, a potent angiogenic growth factor, over expressed during UC was down-regulated by collagen hydrolysate (1.06 +/- 0.25) and collagen (1.76 +/- 0.45) to a greater extent than by mesalamine (2.59 +/- 0.51) and untreated control (4.17 +/- 0.15). The down-regulation of proinflammatory cytokines such as TNF-alpha, IL-1 beta, and IL-6 also follows the same pattern. Histological observations were in accordance with the clinical indicators. Both collagen and collagen hydrolysate treatments showed significant reduction in mucosal damage score and facilitated faster regeneration of damaged mucosa. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available